Case Report: Severe thrombocytopenia induced by adalimumab in rheumatoid arthritis: A case report and literature review
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by persistent joint inflammation. In recent decades, biological agents such as anti-tumor necrosis factor-α (TNF-α) drugs have been applied in the treatment of RA and it achieved great improvement. The treatment has its side e...
Saved in:
Main Authors: | Tiantian Liao (Author), Mengqing Li (Author), Tian Yuan (Author), Qifu Hong (Author), Yu Zeng (Author), Dan Yu (Author), Qiong Yu (Author), Limei Yu (Author), Tao Pu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report
by: M.G. Portuesi, et al.
Published: (2011) -
ADALIMUMAB: NEW OPPORTUNITIES OF RHEUMATOID ARTHRITIS TREATMENT
by: E.I. Alexeeva, et al.
Published: (2009) -
ADALIMUMAB: NEW OPPORTUNITIES OF RHEUMATOID ARTHRITIS TREATMENT
by: E.I. Alexeeva, et al.
Published: (2009) -
PROSPECT IN TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS WITH ADALIMUMAB
by: E.I. Alexeeva, et al.
Published: (2008) -
PROSPECT IN TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS WITH ADALIMUMAB
by: E.I. Alexeeva, et al.
Published: (2008)